4.3 Article

Preparation of Chitosan-Plasmid DNA Nanoparticles Encoding interleukin-12 and their Expression in CT-26 Colon Carcinoma Cells

Journal

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
Volume 14, Issue 2, Pages 181-195

Publisher

CANADIAN SOC PHARMACEUTICAL SCIENCES
DOI: 10.18433/J3TP4T

Keywords

-

Ask authors/readers for more resources

Purpose. Interleukin-12 (Il-12) as a cytokine has been proved to possess antitumor effects via stimulating the immune system. Non-viral gene delivery systems exhibit low toxicity and are easier to prepare compared to their viral counterparts. In this study, we aimed to prepare plasmid DNA loaded chitosan nanoparticles for expression of Il-12 and to evaluate their physicochemical characteristics, cytotoxicity and transfection efficiency in Murine CT-26 colon carcinoma cells. Methods. Nanoparticles were prepared using a complex coacervation process at different N/P ratios and characterized in terms of size, zeta potential, polydispersity index, morphology, encapsulation efficiency and polyplex formation. The cytotoxicities and transfection efficiencies of the prepared polyplexes were evaluated by MTT assay and ELISA (for hIL-12, p70), respectively. Results. Size and zeta potential varied from 76.73 to 867.03 nm and between 5.68 and 16.77 mV, respectively. Strong attachment of the DNA to chitosan was observed after polyplex preparation. Encapsulation efficiencies were high (72.97-94.87%). The transfection efficiencies of the prepared complexes were obviously higher than those of naked pDNA when N/P ratios were between 16 and 60. Maximum level of phIL-12 expression was obtained at (N/P = 16) with mean particle size of 381.83 +/- 82.77 nm (polydispersity index=0.44 +/- 0.066) indicating the improved transfection of pUMVC3-hIL12 about 2.80 times compared to that of the naked pUMVC3-hIL12. Prepared polyplexes were nontoxic to CT-26 cells. Conclusions. Chitosan-DNA nanoparticles at N/P = 16 with minimal cytotoxicity, can be used as suitable candidate for Il-12gene delivery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, Research & Experimental

CTLA-4: As an Immunosuppressive Immune Checkpoint in Breast Cancer

Shaho Ghahremani Dehbokri, Nazila Alizadeh, Alireza Isazadeh, Amir Baghbanzadeh, Soheil Abbaspour-Ravasjani, Khalil Hajiasgharzadeh, Behzad Baradaran

Summary: Breast cancer is a prevalent and deadly disease, and its incidence rate is increasing globally. Conventional treatment approaches, such as surgery, radiation therapy, and chemotherapy, often yield unsatisfactory outcomes. Therefore, developing innovative strategies, such as immunotherapy, is crucial for effective breast cancer therapy. The blockade of immune checkpoints, particularly cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), has shown promising results in cancer immunotherapy. The use of anti-CTLA-4 antibodies alone or in combination with other therapeutic agents enhances the tumor-suppressive effects of the immune system and improves cancer prognosis. Immune checkpoint inhibitors hold great potential for breast cancer treatment. This review discusses the role of CTLA-4 and its therapeutic potential in breast cancer therapeutics.

CURRENT MOLECULAR MEDICINE (2023)

Article Pharmacology & Pharmacy

mir-451a-5p Modulates Breast Cancer Cell Apoptosis, Migration, and Chemosensitivity to Carboplatin through the PTEN Pathway

Monireh Khordadmehr, Hamed Ezzati, Amirali Shahbazfar, Farinaz Jigari-Asl, Behzad Baradaran, Elham Baghbani, Saeed Noorolyai

Summary: The overexpression of miR-451a can enhance the chemosensitivity of breast cancer cells to carboplatin therapy, which may provide a beneficial strategy for future cancer therapy.

PHARMACEUTICAL SCIENCES (2023)

Review Oncology

Chimeric antigen receptor T (CAR-T) cells: Novel cell therapy for hematological malignancies

Samane Abbasi, Milad Asghari Totmaj, Masoumeh Abbasi, Saba Hajazimian, Pouya Goleij, Javad Behroozi, Behrouz Shademan, Alireza Isazadeh, Behzad Baradaran

Summary: Over the last decade, novel therapeutic approaches like CAR-T-cell immunotherapy have transformed the treatment perspective of human malignancies. However, this therapy is associated with side effects and faces challenges in manufacturing, engineering, applications, and toxicities. Further studies are needed to enhance efficacy and minimize adverse events.

CANCER MEDICINE (2023)

Article Oncology

Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?

Farid Ghorbaninezhad, Hajar Alemohammad, Basira Najafzadeh, Javad Masoumi, Mahdi Abdoli Shadbad, Mohammad Shahpouri, Hossein Saeedi, Omid Rahbarfarzam, Behzad Baradaran

Summary: Dexosomes released by dendritic cells can stimulate CD8+ and CD4+ T cell responses, leading to effective anti-tumoral immune responses. Combining dexosomes vaccination with other treatment approaches can significantly increase tumor-specific T cell responses.

CANCER LETTERS (2023)

Article Oncology

In Silico and Experimental Analyses of Long Non-coding RNA TMPO-AS1 Expression in Iranian Patients with Gastric Cancer

Elaheh Mohammadali, Reza Safaralizadeh, Arash Poursheikhani, Tooraj Asvadi, Behzad Baradaran, Shahram Teimourian

Summary: This study aimed to evaluate the expression of lncRNA TMPO-AS1 in Iranian patients with gastric cancer (GC). Results showed that TMPO-AS1 was overexpressed in cancerous tissues and could serve as a biomarker to distinguish tumor tissues from normal ones. However, further research is needed to confirm its potential application in the diagnosis, prognosis, and treatment of GC.

INTERNATIONAL JOURNAL OF CANCER MANAGEMENT (2023)

Article Oncology

Crocin Suppresses Colorectal Cancer Cell Proliferation by Regulating miR-143/145 and KRAS/RREB1 Pathways

Seyed Samad Hosseini, Paria Nazifi, Mohammad Amini, Felor Zargari, Amir Hossein Yari, Behzad Baradaran, Soltanali Mahboob, Ahad Mokhtarzadeh

Summary: The study showed that crocin decreases cell viability in colorectal cancer cells by upregulating miR-143/145 expression and decreasing KRAS and RREB1 expression dose-dependently. Furthermore, crocin treatment also led to the inactivation of AKT by decreasing its phosphorylation, suggesting a potential inhibitory effect on CRC cell proliferation.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2023)

Article Oncology

MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2

Behnaz Mansoori, Shiva Kiani, Alireza Ashrafi Mezajin, Pouyan Zandi, Homadokht Banaie, Davoud Rostamzadeh, William C. Cho, Pascal H. G. Duijf, Behzad Mansoori, Behzad Baradaran

Summary: MiR-143-5p expression is lower in breast cancer tissues compared to normal tissues and low expression is associated with poor prognosis in ER-positive breast cancer patients. Restoration of miR-143-5p suppresses metastasis, reduces cell proliferation, stemness, and promotes apoptosis in ER-positive breast cancer cells through direct targeting of HMGA2. Restoring miR-143-5p could be a promising therapeutic approach for ER-positive breast cancer.

CLINICAL BREAST CANCER (2023)

Review Multidisciplinary Sciences

Nanoparticles for imaging-guided photothermal therapy of colorectal cancer

Omid Rahbar Farzam, Niloofar Mehran, Farzaneh Bilan, Ehsan Aghajani, Reza Dabbaghipour, Ghazale Asemani Shahgoli, Behzad Baradaran

Summary: Colorectal cancer, a common malignancy with high mortality, can be effectively treated using imaging-guided photothermal therapy combined with nanotechnology. This approach minimizes side effects and improves treatment outcomes, making it significant for colorectal cancer treatment.

HELIYON (2023)

Article Rheumatology

Serum Levels of Long Non-coding RNAs NEAT1, GAS5, and GAPLINC Altered in Rheumatoid Arthritis

Roghayeh Tofigh, Mohammadali Hosseinpourfeizi, Reza Safaralizadeh, Sepideh Ghoddusifar, Behzad Baradaran

Summary: This study identifies NEAT1, GAS5, and GAPLINC as promising serological biomarkers in rheumatoid arthritis (RA). The reduced expression of NEAT1 and GAS5 suggests their potential roles as diagnostic and prognostic markers, while the significantly elevated average expression of GAPLINC in RA patients' serum samples indicates its potential as a biomarker candidate for disease stratification. TMEVPG1, on the other hand, displayed unaltered expression levels in RA samples.

CURRENT RHEUMATOLOGY REVIEWS (2023)

Article Biology

The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

Rozhin Dabbaghi, Reza Safaralizadeh, Shima Rahmani, Nesa Barpour, Mohammadali Hosseinpourfeizi, Ali Rajabi, Behzad Baradaran

Summary: This study investigates the role of T-bet, IFN-gamma, and MEG3 in the pathogenesis of multiple sclerosis (MS) and their potential as diagnostic and therapeutic targets. The results show that T-bet expression is elevated in treatment-naive relapsing-remitting MS (RRMS) patients compared to healthy individuals. RRMS patients treated with different disease modifying therapies (DMTs) exhibit downregulated T-bet and MEG3 expression levels, with more pronounced effects in females. The correlation between T-bet and MEG3 and between IFN-gamma and T-bet is observed in healthy individuals, while a strong positive correlation is found between MEG3 and IFN-gamma in RRMS patients treated with Glatiramer Acetate (GA). Remarkably, RRMS patients treated with Dimethyl Fumarate (DMF) show a significant positive correlation between T-bet and MEG3. These findings suggest the diagnostic potential of T-bet in RRMS and indicate the need for further exploration of the interplay between MEG3, T-bet, and IFN-gamma in RRMS patients.

BMC RESEARCH NOTES (2023)

Review Materials Science, Biomaterials

Regulation of Dendritic Cell Functions by Vitamins as Promising Therapeutic Strategy for Immune System Disorders

Zahra Ghahramanipour, Shiva Alipour, Javad Masoumi, Arman Rostamlou, Amirhossein Hatami-Sadr, Javad Ahmadian Heris, Bahar Naseri, Mahdi Jafarlou, Behzad Baradaran

Summary: A functional immune system is crucial for protecting us from infections, tumors, or autoimmune disorders. Micronutrients, particularly vitamins, play important roles in maintaining immune system balance. This review focuses on the roles of vitamins (D, E, A, C) and dendritic cells' subsets in immune processes, including functions, maturation, and cytokine production. Current studies show significant benefits of these vitamins, such as the control of dendritic cells' function and maturation by vitamin E, and the immunoregulatory and anti-inflammatory role of vitamin D. The metabolite of vitamin A, retinoic acid, influences T cell differentiation, and vitamin C has antioxidant effects on dendritic cells. The correlation between vitamin levels and allergic diseases or autoimmunity disorders is also discussed based on previous research.

ADVANCED BIOLOGY (2023)

Article Oncology

Knockdown of SIX4 inhibits pancreatic cancer cells via apoptosis induction

Mohammad Heiat, Ehsan Rezaei, Javad Gharechahi, Masoumeh Abbasi, Javad Behroozi, Mohammad Ali Abyazi, Behzad Baradaran

Summary: Silencing SIX4 inhibits the survival, migration, and invasion ability of pancreatic cancer cells, increases apoptosis and autophagy rates, and reduces mitochondrial membrane potential. Furthermore, knockdown of SIX4 affects the expression of genes related to apoptosis and metastasis. Overall, SIX4 plays a critical role in the development of pancreatic cancer.

MEDICAL ONCOLOGY (2023)

Review Oncology

VISTA and its ligands: the next generation of promising therapeutic targets in immunotherapy

Najibeh Shekari, Dariush Shanehbandi, Tohid Kazemi, Habib Zarredar, Behzad Baradaran, Seyed Amir Jalali

Summary: This article summarizes current evidence on V-domain immunoglobulin suppressor of T cell activation (VISTA), its related ligands, their interactions and effects, as well as preclinical and clinical targeting agents. Investigating VISTA ligands helps understand their functions and roles, and may facilitate the discovery of alternative therapeutic approaches targeting the VISTA pathway.

CANCER CELL INTERNATIONAL (2023)

Article Genetics & Heredity

MicroRNAs and their vital role in apoptosis in hepatocellular carcinoma: miRNA-based diagnostic and treatment methods

Masoumeh Hajizadeh, Farnaz Hajizadeh, Sevil Ghaffarei, Mohammad Amin Doustvandi, Khadijeh Hajizadeh, Seyyed Mohammad Yaghoubi, Fateme Mohammadnejad, Nadia Allahyarzadeh Khiabani, Pegah Mousavi, Behzad Baradaran

Summary: This review summarizes the role and potential efficacy of miRNAs in promoting and inhibiting cell proliferation and apoptosis in HCC, as well as the role of miRNAs in therapy resistance in HCC.
Article Medicine, Research & Experimental

MiR-145 inhibits cell migration and increases paclitaxel chemosensitivity in prostate cancer cells

Maryam Tohidast, Neda Memari, Mohammad Amini, Seyed Samad Hosseini, Asiyeh Jebelli, Mohammad Amin Doustvandi, Behzad Baradaran, Ahad Mokhtarzadeh

Summary: This study demonstrates that the combination of miR-145 and paclitaxel can inhibit cell proliferation and migration in prostate cancer cells, and enhance chemosensitivity. This combination therapy may be a promising approach for the treatment of prostate cancer.

IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES (2023)

No Data Available